PODXL and breast carcinoma: In agreement with this hypothesis, a previous work of our group demonstrated that PODXL expressed on MCF-7 breast cancer cell line accumulates at the immune synapse formed with NK cells and inhibits NK cell activity as well as agonist-induced CD4+ T and CD8+ T cell proliferation (35).